Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
260 | 3715 | 39.4 | 68% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PLATINUM BASED DRUG | Address | 44 | 100% | 0% | 16 |
2 | JM216 | Author keyword | 35 | 86% | 0% | 18 |
3 | PLATINUM COMPLEXES | Author keyword | 34 | 19% | 4% | 159 |
4 | SATRAPLATIN | Author keyword | 30 | 68% | 1% | 27 |
5 | PLATINUMII COMPLEXES | Author keyword | 29 | 32% | 2% | 75 |
6 | BBR3464 | Author keyword | 23 | 79% | 0% | 15 |
7 | DINUCLEAR PLATINUM | Author keyword | 20 | 100% | 0% | 9 |
8 | TRANSPLATIN | Author keyword | 18 | 49% | 1% | 27 |
9 | TRANS PLATINUM | Author keyword | 18 | 89% | 0% | 8 |
10 | TRANS PLATINUM COMPLEXES | Author keyword | 14 | 100% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | JM216 | 35 | 86% | 0% | 18 | Search JM216 | Search JM216 |
2 | PLATINUM COMPLEXES | 34 | 19% | 4% | 159 | Search PLATINUM+COMPLEXES | Search PLATINUM+COMPLEXES |
3 | SATRAPLATIN | 30 | 68% | 1% | 27 | Search SATRAPLATIN | Search SATRAPLATIN |
4 | PLATINUMII COMPLEXES | 29 | 32% | 2% | 75 | Search PLATINUMII+COMPLEXES | Search PLATINUMII+COMPLEXES |
5 | BBR3464 | 23 | 79% | 0% | 15 | Search BBR3464 | Search BBR3464 |
6 | DINUCLEAR PLATINUM | 20 | 100% | 0% | 9 | Search DINUCLEAR+PLATINUM | Search DINUCLEAR+PLATINUM |
7 | TRANSPLATIN | 18 | 49% | 1% | 27 | Search TRANSPLATIN | Search TRANSPLATIN |
8 | TRANS PLATINUM | 18 | 89% | 0% | 8 | Search TRANS+PLATINUM | Search TRANS+PLATINUM |
9 | TRANS PLATINUM COMPLEXES | 14 | 100% | 0% | 7 | Search TRANS+PLATINUM+COMPLEXES | Search TRANS+PLATINUM+COMPLEXES |
10 | BBR 3464 | 12 | 86% | 0% | 6 | Search BBR+3464 | Search BBR+3464 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BISPLATINUM COMPLEXES | 203 | 81% | 3% | 124 |
2 | INTRASTRAND CROSS LINK | 189 | 82% | 3% | 110 |
3 | ANTICANCER DRUG CISPLATIN | 176 | 54% | 6% | 226 |
4 | ANTITUMOR DRUG CIS DIAMMINEDICHLOROPLATINUMII | 163 | 72% | 3% | 128 |
5 | TRANS DIAMMINEDICHLOROPLATINUMII | 141 | 74% | 3% | 104 |
6 | CIS DIAMMINEDICHLOROPLATINUMII | 87 | 23% | 9% | 330 |
7 | TRANS GEOMETRY | 66 | 79% | 1% | 42 |
8 | PLATINUM ANTITUMOR COMPLEXES | 65 | 81% | 1% | 39 |
9 | PLANAR LIGANDS | 64 | 82% | 1% | 37 |
10 | JM216 | 62 | 92% | 1% | 24 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Effect of chirality in platinum drugs | 2015 | 3 | 142 | 68% |
Synthetic Methods for the Preparation of Platinum Anticancer Complexes | 2014 | 33 | 315 | 78% |
The resurgence of platinum-based cancer chemotherapy | 2007 | 1269 | 96 | 34% |
Current status of platinum-based antitumor drugs | 1999 | 1191 | 159 | 70% |
Third row transition metals for the treatment of cancer | 2015 | 2 | 46 | 59% |
Structure, recognition, and processing of cisplatin-DNA adducts | 1999 | 1487 | 294 | 41% |
Metal-based anticancer chemotherapeutic agents | 2014 | 29 | 51 | 47% |
Targeting and delivery of platinum-based anticancer drugs | 2013 | 103 | 205 | 22% |
Platinum complexes as anticancer agents | 2006 | 203 | 132 | 61% |
Cellular processing of platinum anticancer drugs | 2005 | 1350 | 214 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLATINUM BASED DRUG | 44 | 100% | 0.4% | 16 |
2 | JIANGSU PROV HITECH BIOMED | 11 | 34% | 0.7% | 26 |
3 | STATE PLATINUM GRP MET | 6 | 71% | 0.1% | 5 |
4 | KILU | 6 | 100% | 0.1% | 4 |
5 | ENSINO AERONAUT | 4 | 67% | 0.1% | 4 |
6 | PLATFORM TRANSLAT CANC THER Y | 4 | 34% | 0.3% | 10 |
7 | HEAVY MET | 4 | 12% | 0.8% | 29 |
8 | COMANDO AERONAUT | 3 | 100% | 0.1% | 3 |
9 | DEPENS | 3 | 100% | 0.1% | 3 |
10 | STATE ADV TECHNOL PGMS | 3 | 100% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000189525 | CISPLATIN RESISTANCE//PLATINUM DNA ADDUCTS//HUMAN OVARIAN CANCER CELL LINE |
2 | 0.0000171001 | DIMETHYL SULFOXIDE COMPLEXES//SYNTHESIS OF PTII SULFOXIDE COMPLEXES//SULFOXIDE COMPLEXES |
3 | 0.0000156911 | LEHRSTUHL PHARMAZEUT CHEM 2//GRP RECH ONCOL ENDOCRINOL MOL//PORPHYRIN PLATINUM CONJUGATES |
4 | 0.0000153624 | LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077 |
5 | 0.0000150407 | ASSOC SAO BENTO DE ENSINO//DEOXYALLIIN//HNMR UNIT |
6 | 0.0000142848 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
7 | 0.0000114054 | NUCLEOBASE COMPLEXES//URACIL COMPLEXES//1 METHYLCYTOSINE |
8 | 0.0000113444 | AMINOPHOSPHONATE LIGAND//CIS PTII COMPLEX OF 3 AMINOFLAVONE//CIS BIS3 AMINOFLAVONEDICHLOROPLATINUMII |
9 | 0.0000106270 | NAMI A//SCI INGN CHIM//BIOORGANOMETALLIC CHEMISTRY |
10 | 0.0000094514 | DNA CONSTITUENTS//2 AMINOMETHYL BENZIMIDAZOLE//AMINO ACID ESTER HYDROLYSIS |